WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Merck to Appeal EU Regulator’s Decision to Reject COVID-19 Drug 27/02/2023 Stefan Anderson Merck will appeal the recommendation by the Europe Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) that the European Medicines Agency (EMA) rejects its COVID-19 antiviral, Lagevrio (molnupiravir). The decision comes after months of deliberation by European regulators, who began looking at Lagevrio, in November 2021. The CHMP said there was a lack […] Continue reading -> Posts navigation Older postsNewer posts